Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease

被引：1
|
作者：
Rossing, Peter [1 ,2 ]
机构：
[1] Steno Diabet Ctr Copenhagen, Complicat Res, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark
[2] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 15卷 / 12期
关键词：
diabetes; chronic kidney disease; aldosterone; microalbuminuria; mineralocorticoid receptor antagonists; SPIRONOLACTONE; PROGRESSION; NEPHROPATHY;
D O I：
10.2215/CJN.16201020
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1696 / 1698
页数：3
相关论文
共 50 条
  • [41] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Scott Cohen
    Hillel Sternlicht
    George L. Bakris
    [J]. Current Diabetes Reports, 2022, 22 : 213 - 218
  • [42] Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease
    Ivkovic, Vanja
    Bruchfeld, Annette
    [J]. CLINICAL KIDNEY JOURNAL, 2024, 17 (04)
  • [43] Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
    Ortiz, Alberto
    Ferro, Charles J.
    Balafa, Olga
    Burnier, Michel
    Ekart, Robert
    Halimi, Jean-Michel
    Kreutz, Reinhold
    Mark, Patrick B.
    Persu, Alexandre
    Rossignol, Patrick
    Ruilope, Luis M.
    Schmieder, Roland E.
    Valdivielso, Jose M.
    Del Vecchio, Lucia
    Zoccali, Carmine
    Mallamaci, Francesca
    Sarafidis, Pantelis
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) : 10 - 25
  • [44] New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure
    Irene Capelli
    Lorenzo Gasperoni
    Marco Ruggeri
    Gabriele Donati
    Olga Baraldi
    Giovanni Sorrenti
    Maria Turchese Caletti
    Valeria Aiello
    Giuseppe Cianciolo
    Gaetano La Manna
    [J]. Journal of Nephrology, 2020, 33 : 37 - 48
  • [45] New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure
    Capelli, Irene
    Gasperoni, Lorenzo
    Ruggeri, Marco
    Donati, Gabriele
    Baraldi, Olga
    Sorrenti, Giovanni
    Caletti, Maria Turchese
    Aiello, Valeria
    Cianciolo, Giuseppe
    La Manna, Gaetano
    [J]. JOURNAL OF NEPHROLOGY, 2020, 33 (01) : 37 - 48
  • [46] Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Chronic Kidney Disease
    Khan, Mohammad Saud
    Khan, Muhammad Shahzeb
    Moustafa, Abdelmoniem
    Anderson, Allen S.
    Mehta, Rupal
    Khan, Sadiya S.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 643 - 650
  • [47] Non-steroidal mineralocorticoid receptor antagonists and cardiorenal outcomes in chronic kidney disease
    Lo, Kevin Bryan
    Rangaswami, Janani
    Vaduganathan, Muthiah
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (04) : 845 - 854
  • [48] Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease
    Verma, Ashish
    Patel, Ankit B.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (05): : 261 - 263
  • [49] The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges
    Yang, Pingping
    Huang, Tianlun
    Xu, Gaosi
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (09): : 1342 - 1349
  • [50] Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Diabetic Nephropathy Miniperspective
    Piotrowski, David W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (18) : 7957 - 7966
12345